Business Wire

Winners Announced in Prestigious GCCA Photo Competition Which Highlights Beauty and Essential Role of Concrete Throughout World

Share

A stunning image of a skateboard park in the United Arab Emirates has been named Concrete in Life Photo of the Year. It wins a top prize of $10,000 (ten thousand US dollars) in a global competition, which highlights the essential role that concrete plays around the world.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230215005136/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Ferdz Bedana, winner Urban Concrete Professional and overall winner, Concrete in Life Photo of Year. Location Sharjah, UAE

The photo, taken by professional photographer, Ferdz Bedana, in Sharjah, was announced as the overall winner in a live Instagram broadcast, on 15th February. It was selected from more than 14,000 photos submitted by both amateur and professional photographers from every continent, in the annual competition run by the Global Cement and Concrete Association.

Thomas Guillot, GCCA Chief Executive said: “Concrete is the second most used substance on earth after water and plays a vital part in modern infrastructure and society. Through the work of the GCCA and our members, to implement our 2050 Net Zero Roadmap, we are working hard and making progress in reducing its environmental impact. These amazing photos capture the appeal of concrete design and the essential role it plays in modern life and communities everywhere.”

Entrants from around the world submitted photos across four categories: concrete infrastructure, concrete beauty and design, urban concrete, and concrete in daily life, with each section divided between professional photographers and amateurs, often with smart phones. The breadth and variety of all the entries highlight the way concrete supports life around the world, from the giant to the small form, as well as the material’s grace, beauty and crucial supporting role.

Eight category winners each receive a prize of $2,500 (two thousand, five hundred US dollars) each. As well as Ferdz Bedana’s skateboarder image, the category winners include images of a waterfall and a roller-skater race, both taken in Indonesia, a stunning city interchange in China, rice mills in Bangladesh, a university building in Mexico, a metro station in Dubai and a Mosque in Istanbul, Turkey.

Ferdz Bedana who took the overall Concrete in Life Photo of Year in Sharjah, said: “It’s a great honour to be the overall winner of the Concrete in Life 2022 competition and spread the story of how concrete is a big contribution in our life. I was interested to take a photo of this skatepark when I saw a boy enjoying playing in a substantially artistic concrete design.”

Chris George, Content Director at Digital Camera World, and one of the competition judges said about the winning photo: “This was an amazing capture, that perfectly shows the energy of skateboarding against the organic form of the manmade structure.”

Fellow judge, freelance writer and photographer Norman Miller added: “It’s a real skill to capture fast moving subject while showing mastery of framing and control of lighting.”

Thomas Guillot, GCCA Chief Executive added: “Congratulations to Ferdz Bedana and all our category winners. Check out our website to see all the shortlisted entries who were all outstanding.”

The GCCA and its member companies, which account for 80% of global cement production capacity outside of China, as well as key Chinese manufacturers, are committed to reducing and eliminating CO2 emissions through implementation of the Concrete Future - 2050 Net Zero Roadmap – the first heavy industry to set out such a detailed plan.

Notes to editors:

Images available for media to use here .

Video of Instagram broadcast announcing winners available here .

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

For further details, or interview requests:
Simon Thomson, Head of Media, GCCA
simon.thomson@gccassociation.org / +44 7380 972282

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Kinaxis Positioned Highest on Ability to Execute in the Gartner® Magic Quadrant™ for Supply Chain Planning Solutions26.4.2024 19:03:00 EEST | Press release

Kinaxis® Inc. (TSX:KXS), a global leader in end-to-end supply chain orchestration, today announced it has been named a Leader in the 2024 Gartner® Magic Quadrant™ for Supply Chain Planning Solutions. Of the 20 vendors evaluated, Gartner positioned Kinaxis highest on Ability to Execute, marking the company’s 10th consecutive Leaders Quadrant within the report, a complimentary copy of which can be downloaded here. Kinaxis attributes its position to its patented concurrency approach and a proven track record of delivering innovative solutions against the foundation of its leading vision through the use of advanced technology such as AI, ML, and an intuitive user experience. Bolstered by a rich ecosystem of third-party implementation partners, Kinaxis continues to demonstrate that regardless of a customer’s industry, size, or maturity level, the company can be counted on to seamlessly orchestrate supply chain networks end-to-end from strategic planning to last-mile delivery. The recognitio

Vertex Announces European Commission Approval for KALYDECO® to Treat Infants With Cystic Fibrosis Ages 1 Month and Older26.4.2024 18:43:00 EEST | Press release

Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted approval for the label expansion of KALYDECO® (ivacaftor) for the treatment of infants down to 1 month of age with cystic fibrosis (CF) who have one of the following mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene: R117H, G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N or S549R. “Today’s approval is an important milestone for the cystic fibrosis community. Treating CF early in life can potentially slow the progression of the disease, which is why it is so important to start treatment from a very young age,” said Carmen Bozic, M.D., Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer, Vertex. As a result of existing access agreements in Austria, Czech Republic, Denmark, Ireland, Norway, Sweden, and The Netherlands, eligible patients will have access to the expanded indication of KALYDECO® (ivacaftor)

Suzano 2023 annual report on Form 20-F26.4.2024 18:22:00 EEST | Press release

Suzano S.A. (B3: SUZB3 | NYSE: SUZ) informs that its 2023 Annual Report on Form 20-F was filed today with the U.S. Securities and Exchange Commission. Holders of the Company’s equity securities can receive hard copies of the Annual Report, including its audited financial statements, without charge by request directed to: ri@suzano.com.br. This document is also available on Suzano’s website (http://ir.suzano.com.br/). For further information, please contact our Investor Relations Department: Phone: (+55 11) 3503-9330 E-mail: ri@suzano.com.br View source version on businesswire.com: https://www.businesswire.com/news/home/20240426289818/en/ Contact information Hawthorn Advisors suzano@hawthornadvisors.com

Takeda Receives Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer26.4.2024 15:30:00 EEST | Press release

Takeda (TSE:4502/NYSE:TAK) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of fruquintinib, a selective inhibitor of vascular endothelial growth factor receptors (VEGFR) -1, -2 and -3 for the treatment of adult patients with previously treated metastatic colorectal cancer (mCRC). The European Commission (EC) will consider the CHMP positive opinion when determining the potential marketing authorization for fruquintinib for mCRC throughout the European Union (EU), Norway, Liechtenstein and Iceland. If approved, fruquintinib will be the first and only selective inhibitor of all three VEGF receptors approved in the EU for previously treated mCRC.1,2 “People living with metastatic colorectal cancer in the European Union currently have limited treatment options, which can lead to poor outcomes. With this positive opinion for fruquintinib, we are one step closer to potentially offering patients a new

MEDIA ALERT: Wolters Kluwer expert comments on European Parliament vote to pass amendment implementing Basel III reforms26.4.2024 15:00:00 EEST | Press release

The European financial landscape saw a milestone event this week, as the EU Parliament passed the Amendment to Regulation (EU) No 575/2013, implementing the Basel III finalization within Europe. This monumental step forward comes with the adoption of the Capital Requirements Regulation (CRR3) amendments, which are part of a broader legislative package, including amendments to Directive 2013/36/EU, known as the Capital Requirements Directive or CRD. Jeroen Van Doorsselaere, Vice President of Global Product & Platform Management, Wolters Kluwer FRR, said: “The adoption of the Capital Requirements Regulation (CRR3) amendments represents a landmark change for the banking industry, designed to strengthen the framework for risk-based capital requirements and address ESG risks. “This is a major overhaul of the capital requirements framework, impacting various aspects, including credit risk, operational risk, market risk, and the capital floor. Whereas other significant jurisdictions, includin

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
HiddenA line styled icon from Orion Icon Library.Eye